presumably, those analysts didnt know the tennis elbow results, so why did the share price re-rate only 2% due to the impressive tennis elbow study results?
Ann: Successful OrthoATI clinical trial, page-35
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $10.27K | 27.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23531 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 61099 | 2 |
View Market Depth
| Last trade - 10.10am 21/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |